Quoin Pharmaceuticals, Ltd. (QNRX) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Quoin Pharmaceuticals, Ltd. (QNRX) Bundle
Gain insights into your Quoin Pharmaceuticals, Ltd. (QNRX) valuation analysis using our state-of-the-art DCF Calculator! Preloaded with real (QNRX) data, this Excel template enables you to adjust forecasts and assumptions to accurately determine the intrinsic value of Quoin Pharmaceuticals.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA | -1.5 | -2.0 | -21.4 | -8.7 | -9.3 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Depreciation | .2 | .1 | .1 | .1 | .1 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
EBIT | -1.8 | -2.1 | -21.5 | -8.8 | -9.4 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Total Cash | 5.2 | .3 | 7.5 | 12.9 | 10.7 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Accounts Payable | .0 | .0 | .9 | .6 | .5 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Capital Expenditure | -.1 | -.1 | -.6 | -.3 | .0 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
Tax Rate, % | -0.25835 | -0.25835 | -0.25835 | -0.25835 | -0.25835 | -0.25835 | -0.25835 | -0.25835 | -0.25835 | -0.25835 |
EBITAT | -1.8 | -1.8 | -8.5 | -8.8 | -9.4 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -1.7 | -1.8 | -8.1 | -9.2 | -9.4 | -.5 | .0 | .0 | .0 | .0 |
WACC, % | 13.29 | 13.28 | 13.27 | 13.29 | 13.29 | 13.28 | 13.28 | 13.28 | 13.28 | 13.28 |
PV UFCF | ||||||||||
SUM PV UFCF | -.5 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | 0 | |||||||||
Net Debt | -2 | |||||||||
Equity Value | 2 | |||||||||
Diluted Shares Outstanding, MM | 1 | |||||||||
Equity Value Per Share | 2.15 |
What You Will Receive
- Customizable Excel Template: A fully editable Excel-based DCF Calculator featuring pre-filled financial data for Quoin Pharmaceuticals, Ltd. (QNRX).
- Comprehensive Data: Access to historical financials and forward-looking projections (highlighted in the yellow cells).
- Flexible Forecasting: Modify key assumptions such as revenue growth, EBITDA %, and WACC to suit your analysis.
- Instant Calculations: Quickly observe how your inputs affect the valuation of Quoin Pharmaceuticals, Ltd. (QNRX).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Layout: Organized for clarity and user-friendliness, complete with step-by-step guidance.
Key Features
- 🔍 Real-Life QNRX Financials: Pre-filled historical and projected data for Quoin Pharmaceuticals, Ltd.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Quoin’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Quoin’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Access the Template: Download and open the Excel file featuring Quoin Pharmaceuticals' preloaded data.
- 2. Modify Assumptions: Adjust key parameters such as growth rates, WACC, and capital expenditures to reflect your analysis.
- 3. View Results Instantly: The DCF model automatically calculates the intrinsic value and NPV based on your inputs.
- 4. Explore Scenarios: Evaluate various forecasts to examine different valuation possibilities.
- 5. Present with Confidence: Deliver professional valuation insights to back your investment decisions for Quoin Pharmaceuticals (QNRX).
Why Choose Quoin Pharmaceuticals Calculator?
- Accuracy: Utilizes real Quoin Pharmaceuticals financials for precise data.
- Flexibility: Allows users to easily test and adjust inputs as needed.
- Time-Saving: Eliminate the complexity of creating a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and attention to detail expected by CFOs.
- User-Friendly: Designed for ease of use, suitable for users without extensive financial modeling skills.
Who Should Use Quoin Pharmaceuticals, Ltd. (QNRX)?
- Investors: Gain insights into the pharmaceutical sector with our comprehensive analysis tools.
- Financial Analysts: Streamline your research with our detailed financial models tailored for the biotech industry.
- Consultants: Easily modify our presentations to meet the specific needs of your clients in healthcare.
- Healthcare Enthusiasts: Enhance your knowledge of pharmaceutical valuation through case studies and market insights.
- Educators and Students: Utilize our resources as a hands-on learning aid in pharmaceutical finance courses.
What the Template Contains
- Preloaded QNRX Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.